ATE114244T1 - Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung. - Google Patents
Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung.Info
- Publication number
- ATE114244T1 ATE114244T1 AT92905462T AT92905462T ATE114244T1 AT E114244 T1 ATE114244 T1 AT E114244T1 AT 92905462 T AT92905462 T AT 92905462T AT 92905462 T AT92905462 T AT 92905462T AT E114244 T1 ATE114244 T1 AT E114244T1
- Authority
- AT
- Austria
- Prior art keywords
- fluticasone propionate
- salt
- oxikonazole
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919103764A GB9103764D0 (en) | 1991-02-22 | 1991-02-22 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE114244T1 true ATE114244T1 (de) | 1994-12-15 |
Family
ID=10690429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92905462T ATE114244T1 (de) | 1991-02-22 | 1992-02-21 | Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0573492B1 (de) |
| AT (1) | ATE114244T1 (de) |
| AU (1) | AU1277792A (de) |
| CA (1) | CA2104677A1 (de) |
| DE (1) | DE69200711T2 (de) |
| DK (1) | DK0573492T3 (de) |
| ES (1) | ES2064166T3 (de) |
| GB (1) | GB9103764D0 (de) |
| GR (1) | GR3015014T3 (de) |
| MX (1) | MX9200728A (de) |
| WO (1) | WO1992014472A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174475A (en) * | 1991-03-26 | 1992-12-29 | Glaxo Inc. | Sequential dosing of antifungal and antiinflammatory compositions |
| GB9823036D0 (en) | 1998-10-22 | 1998-12-16 | Glaxo Group Ltd | Fluticasone lotion having improved vasoconstrictor activity |
| US6479058B1 (en) | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| AR032362A1 (es) * | 2000-08-14 | 2003-11-05 | Glaxo Group Ltd | Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| WO2012023077A1 (en) * | 2010-08-17 | 2012-02-23 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it |
-
1991
- 1991-02-22 GB GB919103764A patent/GB9103764D0/en active Pending
-
1992
- 1992-02-21 AT AT92905462T patent/ATE114244T1/de not_active IP Right Cessation
- 1992-02-21 DE DE69200711T patent/DE69200711T2/de not_active Expired - Fee Related
- 1992-02-21 MX MX9200728A patent/MX9200728A/es not_active IP Right Cessation
- 1992-02-21 CA CA002104677A patent/CA2104677A1/en not_active Abandoned
- 1992-02-21 WO PCT/EP1992/000364 patent/WO1992014472A1/en active IP Right Grant
- 1992-02-21 ES ES92905462T patent/ES2064166T3/es not_active Expired - Lifetime
- 1992-02-21 EP EP92905462A patent/EP0573492B1/de not_active Expired - Lifetime
- 1992-02-21 DK DK92905462.5T patent/DK0573492T3/da active
- 1992-02-21 AU AU12777/92A patent/AU1277792A/en not_active Abandoned
-
1995
- 1995-02-08 GR GR950400256T patent/GR3015014T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9200728A (es) | 1992-10-01 |
| EP0573492A1 (de) | 1993-12-15 |
| EP0573492B1 (de) | 1994-11-23 |
| GR3015014T3 (en) | 1995-05-31 |
| CA2104677A1 (en) | 1992-08-23 |
| WO1992014472A1 (en) | 1992-09-03 |
| DE69200711T2 (de) | 1995-03-30 |
| AU1277792A (en) | 1992-09-15 |
| GB9103764D0 (en) | 1991-04-10 |
| DE69200711D1 (de) | 1995-01-05 |
| ES2064166T3 (es) | 1995-01-16 |
| DK0573492T3 (da) | 1995-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE114244T1 (de) | Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung. | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
| BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
| DE69005951D1 (de) | Medikamente enthaltend Salmeterol und Fluticason. | |
| FI19991893A (fi) | Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö | |
| ES2173111T3 (es) | Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos. | |
| MX9708800A (es) | Compuestos biciclicos aromaticos. | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
| EE9900162A (et) | Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine | |
| EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
| MX9708803A (es) | Compuestos biaromaticos de propinilo o dienilo. | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
| AU3401093A (en) | Therapeutic agent for threatened abortion | |
| AR015190A1 (es) | Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento | |
| SE9000207L (sv) | Laekemedel samt anvaendningen av detsamma | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| ES2161809T3 (es) | Uso de factor proliferativo osteoblastico. | |
| MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
| BR9713044A (pt) | Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |